2023 - Research.com Best Scientist Award
2023 - Research.com Medicine in United States Leader Award
2022 - Research.com Best Scientist Award
2013 - German National Academy of Sciences Leopoldina - Deutsche Akademie der Naturforscher Leopoldina – Nationale Akademie der Wissenschaften Pathology and Forensic Medicine
Adjuvant and Chemoradiotherapy are all intertwined in Oncology research. In most of his Adjuvant studies, his work intersects topics such as Oncology. His research on Tissue microarray and Vimentin is centered around Immunohistochemistry. Vimentin is closely attributed to Immunohistochemistry in his work. As part of his studies on Internal medicine, Ralph H. Hruban frequently links adjacent subjects like Natural history. Ralph H. Hruban conducts interdisciplinary study in the fields of Cancer and Chemoradiotherapy through his works. He integrates several fields in his works, including Adenocarcinoma and Chemotherapy. He conducts interdisciplinary study in the fields of Chemotherapy and Cancer research through his works. Ralph H. Hruban integrates many fields, such as Cancer research and Cancer, in his works.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Dung T. Le;Jennifer N. Uram;Hao Wang;Bjarne R. Bartlett.
The New England Journal of Medicine (2015)
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Siân Jones;Xiaosong Zhang;D. Williams Parsons;D. Williams Parsons;Jimmy Cheng Ho Lin.
Science (2008)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda;Chetan Bettegowda;Mark Sausen;Rebecca J. Leary;Isaac Kinde.
Science Translational Medicine (2014)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Kenneth P. Olive;Michael A. Jacobetz;Christian J. Davidson;Aarthi Gopinathan;Aarthi Gopinathan.
Science (2009)
DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1
Stephan A. Hahn;Mieke Schutte;A. T. M. Shamsul Hoque;Christopher A. Moskaluk.
Science (1996)
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Shinichi Yachida;Siân Jones;Ivana Bozic;Tibor Antal;Tibor Antal.
Nature (2010)
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Sunil R. Hingorani;Emanuel F. Petricoin;Anirban Maitra;Vinodh Rajapakse.
Cancer Cell (2003)
Genomic analyses identify molecular subtypes of pancreatic cancer
Bailey P;Chang Dk;Nones K;Nones K;Johns Al.
Nature (2016)
Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes.
Charles J. Yeo;John L. Cameron;Taylor A. Sohn;Keith D. Lillemoe.
Annals of Surgery (1997)
Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
Sunil R. Hingorani;Lifu Wang;Asha S. Multani;Chelsea Combs.
Cancer Cell (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Johns Hopkins University
Thomas Jefferson University
New York University
Johns Hopkins University
Johns Hopkins University
The University of Texas MD Anderson Cancer Center
Johns Hopkins University
University of Colorado Anschutz Medical Campus
Johns Hopkins University
Johns Hopkins University
Harbin Institute of Technology
Adobe Systems (United States)
University of Michigan–Ann Arbor
Malmö University
Polytechnic University of Turin
Imperial College London
Université du Québec à Rimouski
Pennsylvania State University
Agricultural Research Organization
Norwegian University of Science and Technology
University College London
Northwestern University
Memorial Sloan Kettering Cancer Center
Brigham and Women's Hospital
Yale University
Institute of Tropical Medicine Antwerp